School of Medicine
Showing 21-40 of 45 Results
-
Hector Rodrigo Mendez
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Hector Rodrigo Mendez is a Medical Geneticist from Argentina. Rodrigo completed a residency program in Medical Genetics at Centro Nacional de Genetica Medica – ANLIS (Buenos Aires, Argentina) and a Master’s program in Medical Molecular Biology at Buenos Aires University.
Rodrigo continued his scientific career at a German Genomic Start-up, working as a human geneticist and providing his experience in rare disorders, genomic data (WGS/WES/gene panels) analysis, variant interpretation, and its integration with a deep focus on genotype-phenotype correlation.
Rodrigo’s areas of expertise are rare disorders, NGS technology, Whole Genome Sequencing analysis, and ACMG interpretation guidelines, and his research aims are:
- Collection and analysis of clinical data through deep-learning phenotyping approaches.
- Multi-omic data integration to elucidate complex and rare genetic disorders.
- International collaborations to break down barriers to research participation amongst those who have been under-represented.
At Stanford University, under the supervision of Dr. Matthew Wheeler, he is conducting his postdoctoral research studies to achieve his scientific goals. -
Samuel Montalvo Hernandez
Postdoctoral Scholar, Cardiovascular Medicine
BioI am a clinical exercise physiologist and sport biomechanist interested in human exercise and sports performance. I am a certified performance and sport scientist (CPSS) and a certified strength and conditioning specialist with distinction (CSCS, *D) by the National Strength and Conditioning Association (NSCA). In 2022, I was honored with the 2022 Wu Tsai Human Performance Alliance Post-Doctoral Research Fellowship. As a research exercise and sport scientist, I am interested in understanding the mechanical, molecular, and physiological mechanisms of human performance. Additionally, I am interested in creating new and practical training methods to improve human exercise and sports performance.
-
Connor Galen O'Brien
Postdoctoral Medical Fellow, Cardiovascular Medicine
BioDr. O'Brien is a native of Menlo Park, CA. He attended medical school at Columbia University College of Physicians and Surgeons. At Columbia he was elected to both Alpha Omega Alpha and Gold Humanism Honors Societies. He completed an Internal Medicine residency as well as fellowship in Cardiovascular Medicine at Stanford University. In his third year of fellowship, he was selected Chief Cardiology Fellow.
He is currently a post-doctoral fellow performing regenerative medicine research, specifically studying the role of exosomes in treating cardiomyopathy. In addition to his basic science research, he is also involved in human clinical trials investigating the role of stem cells in treating various forms of cardiomyopathy. -
Rushil Shah, MBBS, DNB, MHS
Postdoctoral Scholar, Cardiovascular Medicine
BioRushil Shah, MBBS, DNB, MHS is actively pursuing a Post-Doctoral Fellowship in Cardiovascular Medicine at Stanford University, CA awarded by the prestigious American Heart Association AF SFRN.
Rushil Shah is currently engaged in several significant research projects at Stanford University such as Purkinje Fiber Modulation for treating Ventricular Fibrillation (VF), Magnetocardiography in patients with cardiac arrhythmias, MRI-guided Stereotactic Radio ablation for Ventricular Tachycardia, Creating an MRI-compatible Large animal isolated heart model (Langendorff’s Apparatus), and pulsed field ablation (PFA) of the heart. Up until now they were also working on developing a Shared Decision-Making Tool for AF Stroke Prevention as part of the ENHANCE-AF trial under Paul J. Wang, MD.
Rushil recently completed another three-year long Post-Doctoral Research Fellowship in Cardiac Electrophysiology at Johns Hopkins Medical Institutions, Baltimore, MD, United States. Rushil conducted translational research centered on advancements in Cardiac Magnetic Resonance Imaging, VT Ablation, Atrial Fibrillation, Cardiac Sarcoidosis, Cardiac Sympathetic Denervation and Hypothermia Induction in the animal experiment lab at Johns Hopkins under the supervision of Harikrishna Tandri, MD, FACC.
Rushil secured his master’s degree in Medical Immunology & Molecular Microbiology from the Johns Hopkins University Bloomberg School in Baltimore, MD, USA.
Previously, Rushil attended medical school at the Topiwala National Medical College & B.Y.L Nair Hospital in Mumbai, India and subsequently, completed his three-years of medicine residency there. Additionally, Dr. Shah has some experience of working as a Hospitalist in a Cardiology Care Unit (CCU) under the supervision of Yash Lokhandwala, MD, DM at Bandra HFH in Mumbai.
Dr. Shah recently got ECFMG-certified to actively practice medicine in the United States. Rushil is a member of the American Heart Association, Dallas, TX and the Heart Rhythm Society in Washington DC. Rushil aspires to complete his cardiology training and become a cardiac electrophysiologist here in the United States. -
Disha Sharma
Postdoctoral Scholar, Cardiovascular Medicine
BioI am currently a Postdoctoral Fellow with Dr. Thomas Quertermous at Stanford University. I have joined the lab with more than 7 years of research experience in the field of computational biology wherein I have worked with multi-omics data for multiple diseases to get a deeper understanding of the disease identification and progression.
My background in engineering and bioinformatics provide an excellent background for the studies proposed in this application, which proposes to investigate the genetics and genomics of smooth muscle cell biology in the context of vascular disease. I first pursued a Bachelor's in Biotechnology program at one of the premier institutes in India, Banasthali Vidyapeeth and received my degree in 2007. After qualifying with the IIT-JAM exam in 2010, I joined the Master’s in Science (Biotechnology) program at the prestigious Indian Institute of Technology Roorkee in a program of engineering and technology. After my Master's, I joined Dr. Vinod Scaria’s lab at CSIR-IGIB as a Project Fellow. During the tenure as Project fellow from 2012-2014, I had the opportunity to work with different transcriptomics data from model organisms including zebrafish, rat and human cell lines to understand the role of long non-coding RNAs and miRNAs. I also worked on clinical datasets of autoimmune disorders. With one and half years of research experience and a UGC fellowship awarded through the NET-JRF examination, I continued working with Dr. Vinod Scaria to pursue my PhD. My research interest for the degree focused on the identification and characterization of circular RNAs, and this work has now been published in multiple manuscripts listed below. Over the years at CSIR-IGIB, I have had the chance to work on interesting ideas with multiple collaborating groups. One of them was Dr. Sridhar Sivasubbu, with whom I worked to understand the transcript-level interactions between mitochondria and the nucleus, using zebrafish as a model organism.
In view of my interest in the translational aspects of biology, I obtained the opportunity to work as part of the GUaRDIAN Consortium with Dr. Vinod Scaria and Dr. Sridhar Sivasubbu at CSIR-IGIB. This pioneering project is the largest network of researchers and clinicians in India pursuing sequencing patient DNAs to identify rare SNVs and structural variants responsible for muscular dystrophy in these patients. In the interest of advancing genomics in clinical and healthcare settings, I was selected as Intel Fellow 2019 to work for the Intel-IGIB collaboration focussing on “Accelerating Clinical Analysis and Interpretation of Genomic Data through advanced tools/libraries”. Our project was selected among top 3 from 50 premier research institutes and I was awarded the Intel-India Fellowship for a year to pursue this project. I was also part of the core team of IndiGen (Genomes for Public Health in India). With the spread of COVID-19 around the world, our group contributed by sequencing and analysing COVID19 genomes to get a better understanding of the disease and I had the opportunity to be part of the core team to analyse the viral sequencing datasets and viral assembly.
I am extremely pleased to have joined the Quertermous lab at Stanford to the study of the molecular mechanisms of cardiovascular disease. Work that I am pursuing in this laboratory, and proposed in this application, are directly in line with my personal aspiration to start an independent career in the field of scientific research to work on projects with high translational value and of interest to the public health. -
Laurens van de Wiel
Postdoctoral Scholar, Cardiovascular Medicine
BioLaurens van de Wiel is Dutch scientist from Berghem, The Netherlands. Laurens spent his undergrad in Software Development (BSc, Avans Hogeschool ‘s-Hertogenbosch) and Computing Science (MSc, Radboud University Nijmegen). Laurens continued his career at a start-up, where he created large-scale, real-time analytical software. Laurens continued on his academic trajectory at the Radboudumc in Nijmegen, where he started his PhD in bioinformatics.
During his PhD, Laurens integrated genetic data with protein 3D structures and protein domains. He utilized the skills he obtained before setting out on his academic trajectory; building large-scale, robust, reliable software. Exemplified by the MetaDome Web server (https://stuart.radboudumc.nl/metadome/). During his PhD, he developed novel methodologies for the interpretation of genetic variants of unknown clinical significance and, by integrating structural and evolutionary biology with genomics, Laurens identified 36 novel disease-gene associations for developmental disorders. These discoveries enabled diagnosis for over 500 families worldwide.
Laurens’ areas of expertise are (bioinformatic) software development, data integration of genetic variation with other omics, and his research aims are:
1.) Lessons long-learned in computer science aid computational biology
2.) Multi-omic data integration allows the impact measurement of genetic variation
3.) Diagnosing undiagnosed disorders will uncover novel insights into biology.
4.) International and multidisciplinary collaborations are key in diagnosing rare disorders.
At Stanford University, under guidance of Dr. Matthew Wheeler, he is conducting his postdoctoral studies in line with his research aims.
